Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NUP85 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NACA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR636 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPOR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNHG16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC100506558 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKTIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UQCRFS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DGUOK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPLP0 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR3656 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR9-3HG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RALGPS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on